-
EP1708679
European procedure
Extract from the Register of European Patents
EP About this file: EP1708679
| EP1708679 - PHARMACEUTICAL SPRAY FORMULATION COMPRISING A HYDRO FLUOR ALKANE AND AN ACYLATED CYCLODEXTRIN [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 14.09.2009 Database last updated on 03.09.2024 | Most recent event Tooltip | 05.11.2010 | Change - lapse in a contracting state State(s) deleted from list of lapses: RO | published on 08.12.2010 [2010/49] | Applicant(s) | For:AT
BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
GB
HU
IS
LI
LU
PL
PT
RO
SE
SK
TR
AstraZeneca AB 151 85 Södertälje / SE | [2008/09] |
| Former [2006/41] | For all designated states AstraZeneca AB 151 85 Södertälje / SE | Inventor(s) | 01 /
ROGUEDA, Philippe AstraZeneca R & D Charnwood Bakewell Road Loughborough, Leicestershire LE11 5RH / GB | [2008/09] |
| Former [2006/41] | 01 /
ROGUEDA, Philippe, AstraZeneca R & D Charnwood Bakewell Road Loughborough, Leicestershire LE11 5RH / GB | Representative(s) | Summersell, Richard John AstraZeneca AB, Global Intellectual Property 151 85 Södertälje / SE | [2006/41] | Application number, filing date | 04798662.5 | 24.11.2004 | [2006/41] | WO2004GB04957 | Priority number, date | SE20030003179 | 26.11.2003 Original published format: SE 0303179 | [2006/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2005053637 | Date: | 16.06.2005 | Language: | EN | [2005/24] | Type: | A2 Application without search report | No.: | EP1708679 | Date: | 11.10.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.06.2005 takes the place of the publication of the European patent application. | [2006/41] | Type: | B1 Patent specification | No.: | EP1708679 | Date: | 12.11.2008 | Language: | EN | [2008/46] | Search report(s) | International search report - published on: | EP | 28.06.2007 | Classification | IPC: | A61K31/137, A61K31/167, A61K31/573, A61K9/00 | [2008/09] | CPC: |
A61K31/137 (EP,KR,US);
A61K31/573 (EP,KR,US);
A61K31/167 (EP,KR,US);
A61K47/6951 (EP,US);
A61K9/008 (EP,US);
A61P1/00 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P11/08 (EP);
B82Y5/00 (EP,US)
(-)
|
| Former IPC [2006/41] | A61K9/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/41] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | PHARMAZEUTISCHE SPRAYFORMULIERUNG MIT EINEM HYDROFLUORALKAN UND EINEM ACYLIERTEN CYCLODEXTRIN | [2006/41] | English: | PHARMACEUTICAL SPRAY FORMULATION COMPRISING A HYDRO FLUOR ALKANE AND AN ACYLATED CYCLODEXTRIN | [2006/41] | French: | FORMULATION PHARMACEUTIQUE D'UN SPRAY COMPRENANT UN HYDROFLUOROALCANE ET UNE CYCLODEXTRINE ACYLEE | [2006/41] | Entry into regional phase | 26.06.2006 | National basic fee paid | 28.12.2007 | Designation fee(s) paid | 28.12.2007 | Examination fee paid | Examination procedure | 07.06.2005 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 28.12.2007 | Examination requested [2008/07] | 14.03.2008 | Despatch of a communication from the examining division (Time limit: M04) | 23.04.2008 | Reply to a communication from the examining division | 27.06.2008 | Communication of intention to grant the patent | 29.09.2008 | Fee for grant paid | 29.09.2008 | Fee for publishing/printing paid | Opposition(s) | 13.08.2009 | No opposition filed within time limit [2009/42] | Fees paid | Renewal fee | 30.11.2006 | Renewal fee patent year 03 | 30.11.2007 | Renewal fee patent year 04 | 28.03.2008 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2010/49] |
| Former [2010/11] | RO | 12.11.2008 | Cited in | International search | [A]DE10205087 (PHARMATECH GMBH [DE]) [A] 1-10 * claims 1-8 * * paragraph [0015] - paragraph [0022] * * examples 1,2,4,5,7-9 *; | [A] - WILLIAMS III R O ET AL, "Influence of formulation technique for hydroxypropyl-beta-cyclodextrin on the stability of aspirin in HFA 134a", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, (19990301), vol. 47, no. 2, ISSN 0939-6411, pages 145 - 152, XP004257055 [A] 1-10 * abstract * * page 146, column L, line 36 - page 147, column R, line 8 * DOI: http://dx.doi.org/10.1016/S0939-6411(98)00072-1 | [PA] - STECKEL H ET AL, "A novel formulation technique for metered dose inhaler (MDI) suspensions", INTERNATIONAL JOURNAL OF PHARMACEUTICS, AMSTERDAM, NL, (20041013), vol. 284, no. 1-2, ISSN 0378-5173, pages 75 - 82, XP004580739 [PA] 1-10 * abstract * * table 1 * * page 76, column R, line 18 - page 77, column R, line 4 * DOI: http://dx.doi.org/10.1016/j.ijpharm.2004.07.005 |